Key result
AMPK directly phosphorylates β-arrestin-1 at Serine-330, attenuating NLRP3 inflammasome activation and revealing a novel molecular mechanism for reducing cardiac inflammation in heart failure.
Highlights a novel molecular pathway where AMPK directly phosphorylates β-arrestin-1, offering a new mechanistic target for reducing cardiac inflammation in heart failure and metabolic disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Silva-Neto et al. (2024) conducted an editorial in Heart failure and metabolic disease. AMPK activation was evaluated. AMPK directly phosphorylates β-arrestin-1 at Serine-330, attenuating NLRP3 inflammasome activation and revealing a novel molecular mechanism for reducing cardiac inflammation in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: